Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR 312.23 IND content and format.
21 CFR 312.23 IND content and format., “IND content and format”, is a CFR section of 21 CFR Part 312, Subpart B—Investigational New Drug Application (IND); in force.
https://ontology.bommaritollc.com/id/01a0f094-c494-74e2-9ba1-bcdd75647f2a
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR 312.23 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | IND content and formaten |
| schema:url | |
| skos:prefLabel | 21 CFR 312.23 IND content and format.en |
Related
Cited by (11)eli:cites
- 21 CFR 312.22 General principles of the IND submission.
- 21 CFR 312.30 Protocol amendments.
- 21 CFR 312.305 Requirements for all expanded access uses.
- 21 CFR 312.33 Annual reports.
- 21 CFR 312.42 Clinical holds and requests for modification.
- 21 CFR 312.44 Termination.
- 21 CFR 312.55 Informing investigators.
- 21 CFR 312.8 Charging for investigational drugs under an IND.
- 21 CFR 312.88 Safeguards for patient safety.
- 42 CFR 11.10 What definitions apply to this part?
- 42 CFR 11.28 What constitutes clinical trial registration information?